Abstract:Background: Richter Syndrome (RS) is defined as development of aggressive lymphoma arising from chronic lymphocytic leukemia/Small lymphocytic leukemia (CLL/SLL). Accelerated CLL/SLL (aCLL/SLL) is pathologically defined as a highly proliferative form of CLL/SLL (either expanded proliferation center or Ki-67>40%). The underlying mechanism behind transformation from indolent CLL/SLL to aggressive DLBCL remains largely unknown. The biological difference between RS DLBCL and aCLL/SLL has not been explored yet. Aims: To explore intra- and inter-tumor and immune microenvironment (TME) heterogeneity of RS and aCLL/SLL. To disclose the molecular mechanism underlying transformation from CLL/SLL to DLBCL. Methods: Single-cell RNA sequencing (scRNA-seq) of paired lymph node (LN) and peripheral blood (PB) was done among 2 RS (P1, P2) and 2 aCLL/SLL (P3, P4) patients (pathologically diagnosed in LN, Fig. A) and bioinformatics analysis was conducted. Results: Identification of cell type in 8 samples showed great heterogeneity (Fig. B). Single-cell trajectory analysis was done using “monocle” inferred tumor development and differentiation of each patient. Monoclonal B cells with high Ki-67 expression and high proportion of G2M phase cells were enriched in the end of pseudotime trajectories (Fig. C). Further analysis of CD5, CD20 and CD23 expression alongside pseudotime trajectories were also conducted, indicating that our trajectories could depict the transformation from indolent CLL/SLL to aggressive DLBCL. Therefore, cell states were clustered according to the trajectories. P1 and P2 were clustered as seven groups respectively (P1A-G, P2A-G) and P3 were clustered as three groups (P3A-G). Notably, although minor proportion of proliferating cells were enriched in the end of P4 pseudotime trajectories, clusters could not be split in P4 patients. All cell states groups were mapped to UMAP analysis and the proportion of G2M phase was highest in state G of RS patients. Single-sample GSEA (ssGSEA) analysis was done to disclose the pathway activation in transformation process and found that pathways including cell cycle, TCA cycle, spliceosome, MYC targets, unfolded protein response, epigenetics, DNA repair, glycolysis and oxidative phosphorylation were gradually activated alongside trajectories from state A-G in RS. Moreover, pathways including NOTCH, P53, PI3K-AKT, Antigen processing and presentation, apoptosis, hypoxia and etc. were found significantly upregulated in RS (Fig. E). Further analysis of immune microenvironment of RS and aCLL/SLL showed that exhaustion T cells were significantly enriched in RS lymph node compared with aCLL/SLL, indicating the immune surveillance escape mediated by exhaustion T cells might prompt DLBCL transformation. PDCD1 (PD-1), CTLA4, LAG3, HAVCR2 (TIM3), TIGIT expression were significantly upregulated in exhaustion T cells of RS patients, suggesting potential treatment target of RS for immune checkpoint inhibitors (Fig. F). Image:Summary/Conclusion: Our study was the first one using scRNA-seq to disclose the tumor heterogeneity and immune microenvironment of RS and aCLL/SLL in single-cell dimension. Evolution trajectories from indolent CLL/SLL to aggressive DLBCL were constructed and pathway activation in the process of transformation were further explored. Moreover, immune microenvironment analysis of RS and aCLL/SLL showed that exhaustion T cells were significantly enriched in RS lymph node and immune checkpoints including PDCD1 (PD-1), CTLA4, LAG3, HAVCR2 (TIM3), TIGIT were significantly upregulated in exhaustion T cells of RS patients, suggesting potential treatment target of RS.

Genomic Profiling of Sézary Syndrome Identifies Alterations of Key T Cell Signaling and Differentiation Genes

Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma

Sezary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Their Impact On Survival

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients

Chronic activation profile of circulating CD8+ T cells in Sézary syndrome

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study

Delving into the Metabolism of Sézary Cells: A Brief Review

Sézary Syndrome in West Sweden: Exploring Epidemiology, Clinical Features, and Treatment Patterns in a Registry-Based Retrospective Analysis

Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon

Predictors of Large Cell Transformation in Patients with Sezary Syndrome-A Retrospective Analysis

The future of behavior therapy.

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome

Deficiency of SATB1 Expression in Sézary Cells Causes Apoptosis Resistance by Regulating FasL/CD95L Transcription

P625: single-cell rna sequencing reveals the heterogeneity of tumor cells and immune microenvironment in richter syndrome and accelerated cll

Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma

Risk Factors for Large Cell Transformation in Patients with Sezary Syndrome

Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify Sézary syndrome patients with low blood burden

[Bulk-forming agents as laxatives in geriatric patients].

Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers